BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38378656)

  • 1. Role of exhaled hydrogen sulfide in the diagnosis of colorectal cancer.
    Du P; Tseng Y; Liu P; Zhang H; Huang G; Hu C; Chen J
    BMJ Open Gastroenterol; 2024 Feb; 11(1):. PubMed ID: 38378656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Exhaled Hydrogen Sulfide in the Diagnosis of Colorectal Adenoma.
    Liu N; Tseng Y; Zhang H; Chen J
    Can J Infect Dis Med Microbiol; 2021; 2021():8046368. PubMed ID: 34900068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD.
    Zhang J; Wang X; Chen Y; Yao W
    Respir Care; 2015 Feb; 60(2):251-8. PubMed ID: 25336529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-21 and miR-210 as promising non-invasive biomarkers for the diagnosis and prognosis of colorectal cancer.
    Li G; Wang Q; Li Z; Shen Y
    Rev Esp Enferm Dig; 2020 Nov; 112(11):832-837. PubMed ID: 33054296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies.
    Lin H; Yu Y; Zhu L; Lai N; Zhang L; Guo Y; Lin X; Yang D; Ren N; Zhu Z; Dong Q
    Redox Biol; 2023 Feb; 59():102601. PubMed ID: 36630819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study.
    Yan S; Guo W; Liu Y; Li K; Wang W
    Int J Clin Oncol; 2022 Mar; 27(3):538-544. PubMed ID: 35043284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
    Shi Y; Liu Z
    J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum
    Wang N; Zeng L; Li Z; Zhen Y; Chen H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer.
    Xie H; Chen J; Lv X; Zhang L; Wu J; Ge X; Yang Q; Zhang D; Chen J
    Technol Cancer Res Treat; 2020; 19():1533033820947490. PubMed ID: 32851926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Intelligence System to Determine Risk of T1 Colorectal Cancer Metastasis to Lymph Node.
    Kudo SE; Ichimasa K; Villard B; Mori Y; Misawa M; Saito S; Hotta K; Saito Y; Matsuda T; Yamada K; Mitani T; Ohtsuka K; Chino A; Ide D; Imai K; Kishida Y; Nakamura K; Saiki Y; Tanaka M; Hoteya S; Yamashita S; Kinugasa Y; Fukuda M; Kudo T; Miyachi H; Ishida F; Itoh H; Oda M; Mori K
    Gastroenterology; 2021 Mar; 160(4):1075-1084.e2. PubMed ID: 32979355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Expression of
    Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
    Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS.
    Banik GD; De A; Som S; Jana S; Daschakraborty SB; Chaudhuri S; Pradhan M
    J Breath Res; 2016 May; 10(2):026010. PubMed ID: 27163246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnostic value of hydrogen sulfide breath test for small intestinal bacterial overgrowth].
    Guo HZ; Dong WX; Zhang X; Zhu SW; Liu ZJ; Duan LP
    Zhonghua Nei Ke Za Zhi; 2021 Apr; 60(4):356-361. PubMed ID: 33765706
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression.
    Inagaki K; Kunisho S; Takigawa H; Yuge R; Oka S; Tanaka S; Shimamoto F; Chayama K; Kitadai Y
    Cancer Sci; 2021 Jul; 112(7):2692-2704. PubMed ID: 33964093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
    Li L; Wang A; Cai M; Tong M; Chen F; Huang L
    Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.